Table 2. Top findings from the discovery meta-analysis of lipid response to fenofibrate in GOLDN and ACCORD.
Statistically significant findings | GOLDN | ACCORD | Meta | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||
SNP | Chr | BP | A1 | A2 | Gene | Location | Trait | FRQ | Beta | SE | P | FRQ | Beta | SE | P | P |
rs3841260 | 19 | 19756073 | A | AGCC | ATP13A1 | UTR3 | LDL-C | 0.08 | -0.067 | 0.02 | 1.2*10-3 | 0.08 | -0.323 | 0.07 | 1.8*10-6 | 1.5*10-8 |
| ||||||||||||||||
rs140229040 | 19 | 19699398 | G | GA | PBX4 | intronic | LDL-C | 0.07 | -0.058 | 0.02 | 3.4*10-3 | 0.07 | -0.353 | 0.07 | 3.7*10-7 | 1.6*10-8 |
| ||||||||||||||||
rs17217098 | 19 | 19702384 | A | G | PBX4 | intronic | LDL-C | 0.07 | -0.058 | 0.02 | 3.4*10-3 | 0.07 | -0.352 | 0.07 | 3.8*10-7 | 1.6*10-8 |
| ||||||||||||||||
rs150268548 | 19 | 19494483 | A | G | MAU2/GATAD2A | intergenic | LDL-C | 0.08 | -0.050 | 0.02 | 9.2*10-3 | 0.08 | -0.363 | 0.07 | 8.7*10-8 | 2.0*10-8* |
| ||||||||||||||||
rs73004967 | 19 | 19717056 | G | A | PBX4 | intronic | LDL-C | 0.07 | -0.058 | 0.01 | 3.5*10-3 | 0.07 | -0.342 | 0.07 | 6.4*10-7 | 2.5*10-8 |
| ||||||||||||||||
rs73001065 | 19 | 19460541 | C | G | MAU2 | intronic | LDL-C | 0.07 | -0.050 | 0.02 | 1.0*10-2 | 0.07 | -0.367 | 0.07 | 1.8*10-7 | 4.3*10-8* |
| ||||||||||||||||
Top findings | ||||||||||||||||
| ||||||||||||||||
rs140868651 | 19 | 19432290 | A | AG | MAU2 | intronic | LDL-C | 0.07 | -0.049 | 0.01 | 1.2*10-2 | 0.07 | -0.367 | 0.07 | 1.9*10-7 | 5.1*10-8* |
| ||||||||||||||||
rs57504626 | 19 | 19720399 | T | C | PBX4 | intronic | LDL-C | 0.09 | -0.051 | 0.02 | 5.0*10-3 | 0.09 | -0.300 | 0.06 | 1.1*10-6 | 5.4*10-8+ |
| ||||||||||||||||
rs73004959 | 19 | 19711139 | T | C | PBX4 | intronic | LDL-C | 0.09 | -0.051 | 0.02 | 5.0*10-3 | 0.09 | -0.301 | 0.06 | 1.1*10-6 | 6.2*10-8+ |
| ||||||||||||||||
rs73004962 | 19 | 19713069 | T | A | PBX4 | intronic | LDL-C | 0.09 | -0.051 | 0.02 | 5.0*10-3 | 0.09 | -0.297 | 0.06 | 1.3*10-6 | 6.7*10-8+ |
| ||||||||||||||||
rs73199626 | 3 | 190888563 | C | T | SNAR-I/OSTN | intergenic | TG | 0.14 | -0.084 | 0.02 | 4.7*10-4 | 0.17 | -0.220 | 0.06 | 4.9*10-4 | 8.1*10-7 |
| ||||||||||||||||
rs10990032 | 9 | 105116201 | A | G | GRIN3A/CYL2 | intergenic | TG | 0.06 | -0.155 | 0.04 | 5.4*10-5 | 0.06 | -0.271 | 0.09 | 4.9*10-3 | 1.2*10-6 |
| ||||||||||||||||
rs62041965 | 16 | 79551227 | A | G | WWOX/MAF | intergenic | HDL-C | 0.05 | 0.064 | 0.01 | 1.6*10-6 | 0.06 | 0.298 | 0.12 | 0.01 | 2.6*10-7 |
| ||||||||||||||||
rs72744354 | 15 | 51352875 | A | G | TNFAIP8L3 | intronic | HDL-C | 0.04 | -0.066 | 0.01 | 2.6*10-6 | 0.04 | -0.319 | 0.13 | 0.02 | 4.6*10-7 |
| ||||||||||||||||
rs10090941 | 8 | 142370872 | G | C | GPR20 | intronic | TC | 0.17 | 0.018 | 0.01 | 1.1*10-6 | 0.21 | 0.090 | 0.05 | 0.04 | 1.2*10-6 |
| ||||||||||||||||
rs10090104 | 8 | 142370862 | A | G | GPR20 | intronic | TC | 0.17 | 0.018 | 0.01 | 1.1*10-6 | 0.21 | 0.090 | 0.04 | 0.04 | 1.2*10-6 |
A1, allele 1; A2, allele 2 (A2 is the effect allele); BP, base-pair location; Chr, chromosome; FRQ, allele frequency for A1; Meta, meta-analysis result SE, standard error; TC, total cholesterol; SNP, single-nucleotide polymorphism. 0.01<P<0.05 for ACCORD African Americans* or Hispanics+